Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats
dc.contributor.author | Woods, James H. | en_US |
dc.contributor.author | Tuchman, J. E. | en_US |
dc.contributor.author | Ko, M. C. Holden | en_US |
dc.contributor.author | Wiesenauer, K. | en_US |
dc.contributor.author | Johnson, M. D. | en_US |
dc.date.accessioned | 2006-09-08T19:49:53Z | |
dc.date.available | 2006-09-08T19:49:53Z | |
dc.date.issued | 2000-02 | en_US |
dc.identifier.citation | Ko, M. C. H.; Tuchman, J. E.; Johnson, M. D.; Wiesenauer, K.; Woods, J. H.; Woods, J. H.; (2000). "Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats." Psychopharmacology 148(2): 180-185. <http://hdl.handle.net/2027.42/41969> | en_US |
dc.identifier.issn | 0033-3158 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41969 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10663433&dopt=citation | en_US |
dc.description.abstract | Rationale : By acting on peripheral opioid receptors, opioid agonists can attenuate nociceptive responses induced by a variety of agents. Objectives : This study was conducted to characterize capsaicin-induced thermal hyperalgesia in rats and to evaluate the hypothesis that local administration of either mu or kappa opioid agonists (fentanyl and U50,488, respectively) can attenuate capsaicin-induced nociception. Methods : Capsaicin was administered s.c. in the tail of rats to evoke a nociceptive response, which was measured by the warm-water tail-withdrawal procedure. Either fentanyl or U50,488 was co-administered with capsaicin in the tail to evaluate local antinociceptive effects. In addition, the local antagonism study was performed to confirm the site of action of both opioid agonists. Results : Capsaicin (0.3–10 µg) dose dependently produced thermal hyperalgesia manifested as reduced tail-withdrawal latencies in 45°C water. Co-administration of either fentanyl (0.32–3.2 µg) or U50,488 (10–100 µg) with capsaicin (3 µg) attenuated capsaicin-induced hyperalgesia in a dose-dependent manner. Furthermore, this local antinociception was antagonized by small doses (10–100 µg) of an opioid antagonist, quadazocine, applied s.c. in the tail. However, the locally effective doses of quadazocine, when applied s.c. in the back (i.e., around the scapular region), did not antagonize either fentanyl or U50,488. Conclusions : In this experimental pain model, activation of peripheral mu or kappa opioid receptors can attenuate capsaicin-induced thermal hyperalgesia in rats. It supports the notion that peripheral antinociception can be achieved by local administration of analgesics into the injured tissue without producing central side effects. | en_US |
dc.format.extent | 90589 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; Springer-Verlag Berlin Heidelberg | en_US |
dc.subject.other | Hyperalgesia | en_US |
dc.subject.other | Antinociception | en_US |
dc.subject.other | Neurogenic Inflammation | en_US |
dc.subject.other | Key Words Capsaicin | en_US |
dc.subject.other | Legacy | en_US |
dc.subject.other | Peripheral Opioid Receptor | en_US |
dc.title | Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Psychology (Biopsychology Program), University of Michigan, Ann Arbor, MI 48109–1109, USA, US, | en_US |
dc.contributor.affiliationum | Department of Psychology (Biopsychology Program), University of Michigan, Ann Arbor, MI 48109–1109, USA, US, | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, Ann Arbor, MI 48109-0632, USA, US, | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, Ann Arbor, MI 48109-0632, USA, US, | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, Ann Arbor, MI 48109-0632, USA, US, | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, Ann Arbor, MI 48109-0632, USA, US, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 10663433 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41969/1/213-148-2-180_01480180.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s002130050040 | en_US |
dc.identifier.source | Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.